ABSTRACT By using the indirect immunofluorescence technique, one and the same neuron in the parvocellular part of the paraventricular nucleus has been shown to stain with antisera against three different peptides: PHI (PHI-27), corticotropin-releasing factor (CRF), and enkephalin. This could explain the wellknown parallel increase in plasma prolactin, corticotropin, and growth hormone levels-for example, under certain types of stress-as being due to a concomitant release of PHI-like, CRFlike, and enkephalin-like peptides from the same nerve endings in the median eminence. A hypothetical mechanism for the coordinated release of these three anterior pituitary hormones is discussed.
(1, 2) causes release of prolactin from the anterior pituitary gland in vitro (3) (4) (5) and in vivo (6) . Therefore, this peptide may represent a candidate for the prolactin-releasing factor (7, 8) . However, immunohistochemical studies have so far revealed only single VIP-positive nerve fibers in the medial basal hypothalamus, including the median eminence (9) (10) (11) (12) , from which the hypothalamic-releasing hormone and inhibitory hormone are released into the hypophysial portal blood vessels for transport to the anterior pituitary. More recently it has been demonstrated that PHI-like immunoreactivity [PHI-27; the peptide (P) having NH2-terminal histidine (H) and COOH-terminal isoleucine (I) amide and 27 amino acid residues] (13) is present in a parvocellular paraventriculo-infundibular system, forming a dense fiber network around the portal capillaries (14) . PHI has considerable structural similarities to VIP (13) and causes prolactin release, although it is less potent than VIP in this respect (unpublished data).
In the present communication we report that at least part of the PHI immunoreactive neurons in the parvocellular periventricular hypothalamic nuclei contain two other peptides, one enkephalin-like peptide (15) and one corticotropin-releasing factor (CRF)-like peptide (16) . These (20) was used to investigate the presence of more than one compound in the same neuron. Briefly, after photography of the PHI staining patterns, removal of the coverslip, and rinsing in phosphate-buffered saline, the sections were immersed in acid potassium permanganate, rinsed, incubated with fluorescein isothiocyanate-conjugated antiserum (as control), and, if negative, incubated with enkephalin or CRF antiserum. This procedure was repeated and the final incubation was made with CRF or, alternatively, enkephalin antiserum. For control purposes the antisera were pretreated with an excess of the respective peptide (50 pug of peptide per ml of antiserum diluted 1:10 or 1:100). This abolished all staining patterns described below. Furthermore, each antiserum was pretreated with an excess of either of the other peptides (concentrations as above), Abbreviations: PHI, PHI-27, the peptide (P) having NH2-terminal histidine (H) and COOH-terminal isoleucine (I) amide and 27 amino acid residues; VIP, vasoactive intestinal polypeptide; CRF, corticotropinreleasing factor; ACTH, corticotropin; GH, growth hormone. 895 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. and this treatment did not change the staining patterns described below. RESULTS Numerous PHI and CRF immunoreactive cell bodies were seen mainly in the parvocellular part of the paraventricular nucleus. On adjacent sections enkephalin immunoreactive perikarya were seen with a similar distribution, but many cells containing this immunoreactivity were seen also in other hypothalamic areas. In the median eminence a dense network of PHI, CRF, and enkephalin immunoreactive fibers was observed in the external layer extending along the entire length of this structure into the stalk. Again, enkephalin immunoreactive fibers were seen in many other structures, whereas PHI and CRF had a much more restricted distribution and occurred only in a few other areas in the hypothalamus.
Analysis ofthin adjacent sections revealed that in many cases all three immunoreactivities were present in the same neuronal cell bodies. This was confirmed by the elution-restaining experiments, in which certain cells in the parvocellular paraventricular nucleus were first demonstrated to contain PHI-like (Fig. la) , then enkephalin-like (Fig. lb) , and finally also CRFlike (Fig. 1c) immunoreactivities. There were also cells that seemed to contain either only enkephalin-like or only PHI-like and CRF-like or only enkephalin-like and CRF-like immunoreactivities ( Fig. 1 a-c) . The staining patterns of the three peptides in the median eminence were similar, but due to the small size of the fibers, identity could not be established.
DISCUSSION
It was demonstrated earlier that the parvocellular paraventricular nucleus ofthe rat contains enkephalin (21-23), CRF (24, 25) , and PHI (14) immunoreactive neurons, but these studies dealt with only one peptide at the time and thus the question of occurrence in one and the same neuron was not addressed. The present findings demonstrate that one and the same neuron in the parvocellular part ofthe paraventricular nucleus can contain at least three compounds-a PHI-like, a CRF-like, and an enkephalin-like peptide. However, some cells seemed to contain only one or, alternatively, two of these peptides. Whether this is true or whether the apparent absence of peptide is due to insufficient sensitivity of our technique remains to be elucidated.
According to the classical concept ofHarris (26), the hormone secretion from the anterior pituitary is controlled by hypothalamic factors released into the hypophysial portal system and transported to the gland. Each pituitary hormone may be controlled by releasing or inhibitory factor(s), or both (27, 28) . It is well known that under some conditions, there is a parallel increase in release of several pituitary hormones. Thus, it has been reported that certain types of stress cause release of both ACTH and prolactin (29) (30) (31) (32) and of ACTH and GH (33 
